• 1. Structured crystallization for efficient all-inorganic perovskite solar cells with high phase stability
  Zhen Wang,Ajay K. Baranwal,Muhammad Akmal Kamarudin,Yusuke Kamata,Chi Huey Ng,Manish Pandey,Tingli Ma,Shuzi Hayase J. Mater. Chem. A 2019 7 20390
• 2. Yttrium iodide and bis(trimethylsilyl)methyl complexes of the chelating diamide [ArN(CH2)3NAr]2? (Ar = 2,6-iPr2C6H3)
  F. Geoffrey N. Cloke,Benjamin R. Elvidge,Peter B. Hitchcock,Vanessa M. E. Lamarche J. Chem. Soc. Dalton Trans. 2002 2413
• 3. Yttrium iodide and bis(trimethylsilyl)methyl complexes of the chelating diamide [ArN(CH2)3NAr]2? (Ar = 2,6-iPr2C6H3)
  F. Geoffrey N. Cloke,Benjamin R. Elvidge,Peter B. Hitchcock,Vanessa M. E. Lamarche J. Chem. Soc. Dalton Trans. 2002 2413
• 4. Activity coefficients of ions in gelatin gels
  M. G. T. Shone Trans. Faraday Soc. 1963 59 1231
• 5. Crystal-to-crystal transformations in heterometallic yttrium(iii)–copper(i) iodide derivatives in a confined solvent-free environment: Influence of solvated yttrium cations on the nuclearity and dimensionality of iodocuprate clusters
  Shashank Mishra,Erwann Jeanneau,Henry Chermette,Stéphane Daniele,Liliane G. Hubert-Pfalzgraf Dalton Trans. 2008 620

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Transition metal salts Transition metal iodides
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt
• Catalysts and Inorganic Chemicals Inorganic Compounds

Introduction to Yttrium Iodide (CAS No. 13470-38-7): Applications and Recent Research Developments

Yttrium Iodide, with the chemical formula Y₂I₂O₇, is a compound of significant interest in the field of materials science and pharmaceutical applications. Its unique crystal structure and luminescent properties make it valuable for various industrial and research purposes. This article provides a comprehensive overview of Yttrium Iodide (CAS No. 13470-38-7), highlighting its chemical properties, synthesis methods, and recent advancements in its utilization across different sectors.

The compound is characterized by its high thermal stability and excellent luminescent behavior, which have garnered attention for its use in phosphors, scintillators, and medical imaging technologies. The iodide component in Yttrium Iodide plays a crucial role in modulating its optical properties, making it a preferred choice for developers seeking materials with enhanced radioluminescence characteristics.

In terms of synthesis, Yttrium Iodide (CAS No. 13470-38-7) is typically prepared through the reaction of yttrium oxide with hydrogen iodide at elevated temperatures. This process ensures the formation of a highly pure crystalline structure, which is essential for applications requiring high luminous efficiency. Recent improvements in synthetic methodologies have focused on optimizing reaction conditions to achieve higher yields and purity levels, thereby enhancing the compound's performance in practical applications.

One of the most prominent applications of Yttrium Iodide is in the field of medical imaging. Its ability to emit light when excited by X-rays or gamma rays makes it an ideal candidate for use in scintillation crystals used in computed tomography (CT) scanners and positron emission tomography (PET) devices. The compound's high light output and energy resolution contribute to improved image quality, enabling more accurate diagnoses and treatment planning.

Recent research has also explored the potential of Yttrium Iodide (CAS No. 13470-38-7) in the development of novel drug delivery systems. Studies have demonstrated that yttrium-based nanoparticles can be functionalized to target specific biological markers, facilitating the delivery of therapeutic agents to targeted regions within the body. This approach has shown promise in enhancing the efficacy of treatments for various diseases while minimizing side effects.

The compound's luminescent properties have also been leveraged in optoelectronic devices, such as light-emitting diodes (LEDs) and solar cells. By integrating Yttrium Iodide into these devices, researchers have been able to improve their efficiency and durability. For instance, yttrium-doped phosphors have been used to enhance the color rendering index of white LEDs, providing more natural-looking light output.

In addition to its medical and optoelectronic applications, Yttrium Iodide (CAS No. 13470-38-7) has found utility in advanced materials research. Its unique crystal structure allows it to serve as a host material for rare-earth ions, enabling the development of novel phosphors with tailored luminescent properties. These materials are being explored for use in display technologies, lighting solutions, and even quantum computing applications.

The environmental impact of using Yttrium Iodide has also been a subject of recent studies. Researchers are investigating sustainable synthesis methods that minimize waste generation and energy consumption. Additionally, efforts are being made to develop environmentally friendly disposal techniques for yttrium-based compounds to ensure their safe integration into industrial processes without adverse ecological consequences.

The future prospects for Yttrium Iodide (CAS No. 13470-38-7) appear promising, with ongoing research aiming to uncover new applications and improve existing ones. As technology advances, the demand for high-performance materials like yttrium iodide is expected to grow, particularly in areas such as healthcare diagnostics and renewable energy solutions.

In conclusion, Yttrium Iodide stands as a versatile compound with a wide range of applications across multiple industries. Its unique properties make it indispensable in medical imaging, optoelectronics, and advanced materials science. As research continues to evolve, the potential uses for this compound are likely to expand even further, solidifying its role as a cornerstone material in modern technology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)